MDACC Study Summary 2007-0799

Study Summary
No. 2007-0799:.......Other Studies......Ying Guo......Physical Medicine

Study Summary Title



Study Summary Number:	2007-0799

Study Title:	Quantitative and Clinical Description of Postural Instability in Patient Who Underwent Acute Inpatient Rehabilitation and at Follow-up.

Physician

New Patient Referral



Name:	Ying Guo	Patients Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Dept:	Physical Medicine	Referring MD Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Phone:	713-745-2327 Contact us about clinical trials

General Information



Disease Group:	Other Studies	Supported By:	N/A

Phase of Study:	N/A	Return Visit:	1

Treatment Agents:	None	Home Care:	Only if home care, physical therapy is part of their standard care.

Treatment Loc:	Only at MDACC

Estimated Length of Stay in Houston:	The LOS will not be affected by this protocol


Description/ Intervention:	The goal of this clinical research study is to find out how well you can walk and keep your balance 4 weeks after leaving the inpatient rehabilitation program or after treatment through rehabilitation mobile team at M. D. Anderson.

Study Objectives / Outcomes

Primary Objectives

To determine the change in functional tests of postural control of cancer patients who have completed acute inpatient rehabilitation or complete rehabilitation through mobile team from discharge at 21-60 days (+/- 3) after discharge.

Secondary Objectives

To assess the correlations between the functional tests of postural control, the balance test and the amount of exercise per week.

Study Status Information



Study Activation / Registration Date:	01/10/2008

IRB Review and Approval Date:	01/10/2008

Study Type:	Observational

Recruitment Status:	Closed

Projected Accrual:	N/A

Enrollment Eligibility

If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:

1) Patients, or the legal guardians of patients, must have the ability to understand and willingness to sign a written informed consent document.

2) Patients must be able to ambulate with or without assistant device, without assistance from a person.

3) Patients must have undergone acute inpatient rehabilitation at MDACC or undergone rehabilitation through mobile team.

Exclusion Criteria:

1) Patients who decline to participate or who are determined incapable of completing the research.

2) Active CNS disease, such as clinically-evident metastases or leptomeningeal disease, dementia, or encephalopathy.

3) Patient who is not willing or able to come back for 4+/-1 week routine follow-up.

Links

Registration Number: NCT00601133
Study Information on Clinical Trials Registry (clinicaltrials.gov)